Why choose MacroGenics for your next CDMO project? ✅ Expertise in DS manufacturing ✅ Quality compliance at the forefront ✅ Prioritization of collaboration and communication Contact us at [email protected]. #CDMO #Maryland
Über uns
MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.
- Website
-
http://www.macrogenics.com
External link for MacroGenics, Inc.
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 201-500 Mitarbeiter
- Hauptsitz
- Rockville, MD
- Typ
- Öffentliches Unternehmen
- Gegründet
- 2000
- Spezialitäten
- Autoimmune Disorders, Oncology, Infectious Diseases, Bi-Specific Antibodies, Fc Optimization, and Monoclonal Antibodies
Standorte
-
Primäre
9704 Medical Center Drive
Rockville, MD 20850, US
-
One Corporate Drive
South San Francisco, CA 94080, US
Employees at MacroGenics, Inc.
Aktualisierungen
-
MacroGenics has a strong track record of success with mAbs, bispecifics, and ADCs. With the experience of 20 INDs and manufacturing two commercial products, our experts are here to help you rapidly advance your molecule to market. Contact us at [email protected]. #CDMO #Maryland
-
Ähnliche Seiten
Jobs durchsuchen
Finanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 110.0M